Nowacki P, Dolińska D, Honczarenko K, Zyluk B
Kliniki Hematologii Pomorskiej Akademii Medycznej, Szczecinie.
Neurol Neurochir Pol. 1992 Jul-Aug;26(4):482-9.
The reported analysis comprised 81 patients dying of acute non-lymphoblastic leukaemia type M1, M2, M4 and blastic crises in chronic myelocytic leukaemia. It was observed that the number of cases of cerebellar granular layer atrophy rose markedly in the years 1984-1990 as compared with 1976-1983 (45.4% vs 16.2%). It is suggested that this was due to the introduction of cytostatic treatment schedules with higher doses of cytosine arabinoside (ARAC), especially TAD (6-thioguanine, ARAC, daunorubicin). Cerebellar granular layer atrophy seems to be dependent rather on the cumulative dose of ARAC and not on a single high dose of that drug.
所报道的分析涵盖了81例死于急性非淋巴细胞白血病M1型、M2型、M4型以及慢性粒细胞白血病急变期的患者。据观察,与1976 - 1983年相比,1984 - 1990年小脑颗粒层萎缩的病例数显著增加(45.4%对16.2%)。有人认为,这是由于采用了更高剂量阿糖胞苷(ARAC)的细胞抑制治疗方案,尤其是TAD方案(6 - 硫鸟嘌呤、阿糖胞苷、柔红霉素)。小脑颗粒层萎缩似乎更取决于阿糖胞苷的累积剂量,而非单次高剂量使用该药物。